Andrea Costanzi

About

Andrea Costanzi is a leading figure in the advancement of minimally invasive surgical oncology, with a primary focus on gastric cancer treatment. His major contributions lie in demonstrating the feasibility, safety, and oncologic efficacy of laparoscopic and robot-assisted gastrectomy with D2 lymph node dissection for distal gastric adenocarcinoma. His seminal 2010 paper, with 139 citations, provides critical long-term evidence on 5-year survival rates following this complex procedure, helping to validate minimally invasive approaches against traditional open surgery. Costanzi’s work also extends to comparative analyses of conventional and robot-assisted techniques, as seen in his 2008 study (67 citations), and he has contributed to the broader field of laparoscopic surgery through his experience with adrenalectomy. With a career dedicated to refining surgical techniques and improving patient outcomes, Costanzi’s research has been instrumental in shaping modern, less invasive standards of care for gastric cancer, making him a key reference for surgeons and researchers pursuing innovation in oncologic surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival

   139 citations · 2010
2. 2
   Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures

   67 citations · 2008
3. 3
   Outcomes of laparoscopic adrenalectomy. Clinical experience with 68 patients

   20 citations · 2007
4. 4
   Robot-assisted laparoscopic gastrectomy with D2 dissection for adenocarcinoma: initial experience with 17 patients

   11 citations · 2008

Key Collaborators

Contact & Links